Prof Anastasios John Kanellopoulos | Innovative Leadership | Best Researcher Award

Prof Anastasios John Kanellopoulos | Innovative Leadership | Best Researcher Award

Laservision Ambulatory Surg Center, New York Universty, Grossman Medical School, Greece

Profile 

Orcid

Early Academic Pursuits 🎓

Dr. Anastasios John Kanellopoulos embarked on his academic journey with a strong foundation in Athens, Greece, graduating with highest honors from the prestigious Varvakion High School in 1983. He proceeded to the University of Athens Medical School, where he cultivated his interest in ophthalmology and medicine. Following his foundational medical education, he transferred to the Southern Illinois University School of Medicine, earning his medical degree in 1990. His academic curiosity and commitment to excellence were evident early, setting the stage for a career defined by innovation and impact.

His postgraduate training reflects a relentless pursuit of specialization. Between 1991 and 1994, he completed his ophthalmology residency at the State University of New York at Stony Brook, culminating in his role as Chief Resident in his final year. This rigorous residency program provided him with hands-on experience and leadership training, preparing him for advanced fellowships. His subsequent training at institutions like Harvard Medical School and Cornell University Medical College deepened his expertise in glaucoma, keratoprosthesis, and refractive surgery. These early academic pursuits established him as a dedicated learner and a future leader in his field.

Professional Endeavors 🏥

Dr. Kanellopoulos’s professional journey spans continents and decades. He holds dual roles as a Clinical Professor of Ophthalmology at New York University Medical School and a full-time practitioner at The Laservision Clinical and Research Institute in Athens, Greece. His work bridges academia and clinical practice, showcasing his versatility and dedication to advancing ophthalmology.

In his academic career, Dr. Kanellopoulos has held numerous leadership positions, such as Director of Cornea Transplantation and Refractive Surgery at NYU and Assistant Director of Residency Training at the Manhattan Eye, Ear, and Throat Hospital. These roles highlight his commitment to mentoring young ophthalmologists and shaping the future of the field. His clinical expertise extends to external diseases, corneal transplantation, and refractive surgery, with a focus on delivering innovative and effective treatments.

Contributions and Research Focus 🔬

Dr. Kanellopoulos’s research has been at the forefront of ophthalmological advancements. He has made significant contributions to the development of laser vision correction techniques, corneal transplantation, and glaucoma management. His pioneering work in keratoprosthesis during his fellowship at Harvard Medical School stands out as a hallmark of his dedication to restoring vision for patients with severe corneal damage.

At Laservision Clinical and Research Institute, Dr. Kanellopoulos has established a reputation for integrating cutting-edge technologies into practice. His clinical trials and research projects have provided valuable insights into the application of advanced lasers, cross-linking techniques, and personalized surgical procedures. By merging research with practice, he ensures that patients receive state-of-the-art care while contributing to the broader scientific community.

Accolades and Recognition 🏆

Dr. Kanellopoulos’s excellence has been acknowledged through numerous awards and honors. In 2011, he received the prestigious Leedert J. Lans Distinguished Award from the International Society of Refractive Surgery and the American Academy of Ophthalmology. This recognition highlighted his groundbreaking contributions to refractive surgery and corneal innovations.

He was also honored with the 2016 Visionary Award by the American-European Congress of Ophthalmic Surgery for his exceptional advancements in ophthalmic techniques. In 2018, his contributions to global ophthalmology were celebrated with the Secretariat Award from the American Academy of Ophthalmology. These accolades reflect his influence and dedication to improving patient outcomes worldwide.

Impact and Influence 🌍

Dr. Kanellopoulos’s influence extends far beyond his clinical and academic roles. He has trained countless ophthalmologists, fostering a culture of innovation and excellence among his peers and mentees. His work has not only transformed individual lives by restoring vision but also advanced global ophthalmological practices through collaborations and leadership in international organizations.

He is a sought-after speaker and educator, sharing his expertise at global conferences and workshops. His publications, which span numerous high-impact journals, provide valuable insights into corneal surgery, laser treatments, and glaucoma management. By contributing to the academic and clinical discourse, he has solidified his position as a thought leader in ophthalmology.

Legacy and Future Contributions 🌟

As a visionary in his field, Dr. Kanellopoulos continues to inspire innovation and excellence. His legacy is defined by a combination of groundbreaking research, compassionate patient care, and transformative teaching. Looking ahead, his ongoing work at The Laservision Clinical and Research Institute and NYU promises further advancements in personalized and minimally invasive treatments.

Dr. Kanellopoulos’s dedication to merging technology with medicine ensures that the next generation of ophthalmologists will benefit from his pioneering spirit. His future contributions will likely focus on enhancing global access to advanced treatments, further cementing his impact on the world of ophthalmology. His career exemplifies a commitment to excellence, innovation, and the betterment of human health.

📝Notable Publications

Progressive Keratoconus Treatment with Transepithelial Two-Step Phototherapeutic Keratectomy Combined with Corneal Crosslinking (CXL): Clinical Outcomes and Postoperative Management Including Potential Complications of the Modified Athens Protocol Designed for US-Approved Excimer Laser Specifications

Authors: Anastasios John Kanellopoulos, Alexander J. Kanellopoulos

Journal: Journal of Clinical Medicine

Year: 2024

The Importance of HOA Reduction Measurements to Improving Refractive Surgery Result Outcomes [Response to Letter]

Authors: Anastasios Kanellopoulos, Matthias Maus, Chandra Bala, Cody Hamilton, Sissimos Lemonis, Maria Jockovich, Ramin Khoramnia

Journal: Clinical Ophthalmology

Year: 2024

Progressive Keratoconus Treatment with Transepithelial 2-Step Phototherapeutic Keratectomy Combined with Corneal Cross-Linking (CXL): Clinical Outcomes and Postoperative Management including Potential Complications, of the Modified Athens Protocol

Authors: Anastasios John Kanellopoulos, Alexander J. Kanellopoulos

Journal: Preprints

Year: 2024

Topographic Keratoconus Incidence in Greece Diagnosed in Routine Consecutive Cataract Procedures: A Consecutive Case Series of 1250 Cases over 5 Years

Authors: Anastasios John Kanellopoulos, Alexander J. Kanellopoulos

Journal: Journal of Clinical Medicine

Year: 2024

International Multicenter, Myopic and Myopic Astigmatism Femto LASIK, Customized by Automated Ray-Tracing Ablation Profile Calculation: A Postmarket Study

Authors: Anastasios Kanellopoulos, Matthias Maus, Chandra Bala, Cody Hamilton, Sissimos Lemonis, Maria Jockovich, Ramin Khoramnia

Journal: Clinical Ophthalmology

Year: 2024

Prof Keun-Ah Cheon | Innovative Leadership | Best Researcher Award

Prof Keun-Ah Cheon | Innovative Leadership | Best Researcher Award

Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea

Profile 

Google Scholar 

Early Academic Pursuits 🎓

Dr. Keun-Ah Cheon’s academic journey began at Yonsei University College of Medicine, one of South Korea’s most prestigious medical schools. She earned her Doctor of Medicine (M.D.) degree in 1994 after completing her six-year program, laying the foundation for her career in psychiatry. She pursued a Master’s degree in Medical Science from the same institution between 1996 and 1999. Her master’s thesis, titled “The Effect of Haloperidol on Regional Cerebral Blood Flow Assessed with 99m-Tc-ECD SPECT in Schizophrenic Patients,” reflected her early interest in understanding the neurological underpinnings of psychiatric disorders.

Dr. Cheon’s academic journey continued with a Doctor of Philosophy (Ph.D.) in Child and Adolescent Psychiatry, also from Yonsei University, where she developed a diagnostic instrument for Korean children with ADHD and explored the genetic links between ADHD and the Dopamine D4 receptor gene (DRD4). This work was pivotal in expanding the understanding of ADHD in the South Korean context, aligning her research with both clinical practice and genetic psychiatry.

Professional Endeavors 🩺

Dr. Cheon’s professional career took off at Kwandong University College of Medicine, where she served as Assistant Professor and Director of Child and Adolescent Psychiatry from 2003 to 2008. Her leadership in this role set a strong foundation for her future endeavors. During this period, Dr. Cheon not only contributed to the academic community but also gained hands-on experience as the Director of Child and Adolescent Psychiatry, solidifying her reputation as a leading expert in the field.

In 2009, Dr. Cheon expanded her horizons with a year-long visiting scholar position at the Developmental Neuroimaging Laboratory in the Center for Autism Research at Children’s Hospital of Philadelphia, part of the University of Pennsylvania School of Medicine. This experience exposed her to cutting-edge research in developmental neuroimaging, enabling her to apply advanced techniques and global perspectives to her work in South Korea.

Upon returning to Yonsei University College of Medicine, Dr. Cheon was promoted to Associate Professor in 2010, continuing to direct the Division of Child and Adolescent Psychiatry. In 2017, she was promoted to Professor, a position she continues to hold, making substantial contributions to psychiatric education and research.

Contributions and Research Focus 🧠

Dr. Cheon’s research interests span several critical areas of child and adolescent psychiatry, with a particular focus on developmental disorders such as ADHD and autism. Her early research centered on understanding the genetic foundations of ADHD, specifically investigating the association between ADHD and the Dopamine D4 receptor gene (DRD4). This focus on neurobiological mechanisms highlighted her commitment to bridging clinical psychiatry with molecular science.

As Director of the Severance Autism and Developmental Disorder Center since 2023, Dr. Cheon has expanded her research into autism spectrum disorders. Under her leadership, the center has become a hub for innovative research and treatment strategies, designated by South Korea’s Ministry of Health and Welfare. This role also underscores her ability to translate research findings into real-world therapeutic interventions for children with developmental disorders.

Her contributions are not limited to clinical psychiatry and research; Dr. Cheon is actively involved in the development of diagnostic tools tailored to the South Korean population, reflecting her focus on culturally sensitive psychiatric care. She has made significant strides in improving the understanding of child and adolescent mental health issues in the local context, contributing to a body of work that has influenced national policies and practices.

Accolades and Recognition 🏅

Dr. Cheon’s dedication to the field has earned her numerous accolades. Since March 2024, she has been serving as the President of the Korean Academy of Child and Adolescent Psychiatry (KACAP), a prestigious role that recognizes her leadership and expertise in the field. Her election to this position is a testament to her influence and the respect she commands within the psychiatric community in South Korea.

Additionally, her leadership roles at Yonsei University and beyond have further solidified her reputation as a key figure in psychiatric research and education. As Deputy Director of the Institute of Behavioral Science in Medicine and Director of the Department of Child and Adolescent Psychiatry, Dr. Cheon plays a crucial role in shaping psychiatric research and clinical practice.

Impact and Influence 🌍

Dr. Cheon’s influence extends beyond South Korea. Her work in neuroimaging, autism, and ADHD has earned international recognition, particularly her collaboration with the Center for Autism Research at the Children’s Hospital of Philadelphia. This experience allowed her to integrate global best practices into her research and clinical work, contributing to improved diagnostic and treatment methodologies in South Korea.

As an educator, Dr. Cheon has mentored countless students, residents, and fellows in psychiatry, shaping the next generation of child and adolescent psychiatrists. Her role as a professor at Yonsei University has provided her with a platform to share her expertise and knowledge, influencing both clinical practice and psychiatric education.

Legacy and Future Contributions 🌟

Looking forward, Dr. Cheon’s contributions are poised to leave a lasting legacy in child and adolescent psychiatry. Her leadership at the Severance Autism and Developmental Disorder Center and her presidency at KACAP indicate that she will continue to be a driving force in shaping the future of psychiatric care and research in South Korea.

Her ongoing work in understanding the genetic basis of psychiatric disorders, combined with her commitment to improving diagnostic tools and therapeutic interventions, will likely lead to groundbreaking advancements in the field. As a trailblazer in child and adolescent psychiatry, Dr. Cheon’s influence will undoubtedly continue to grow, ensuring her legacy as a leader in both South Korean and global psychiatry.

Conclusion 🔍

Dr. Keun-Ah Cheon’s career exemplifies a dedication to improving the understanding and treatment of psychiatric disorders in children and adolescents. From her early academic pursuits at Yonsei University to her current leadership roles, her contributions to psychiatry have had a profound impact both nationally and internationally. Through her research, clinical work, and mentorship, Dr. Cheon has cemented her place as a pivotal figure in child and adolescent mental health, and her legacy will continue to shape the field for years to come.

📝Notable Publications

Prevalence of autism spectrum disorders in a total population sample

Authors: Y.S. Kim, B.L. Leventhal, Y.J. Koh, E. Fombonne, E. Laska, E.C. Lim, K.A. Cheon, et al.
Journal: American Journal of Psychiatry
Volume: 168
Issue: 9
Pages: 904-912
Year: 2011

Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders

Authors: P.H. Lee, V. Anttila, H. Won, Y.C.A. Feng, J. Rosenthal, Z. Zhu, E.M. Tucker-Drob, et al.
Journal: Cell
Volume: 179
Issue: 7
Pages: 1469-1482.e11
Year: 2019

The reliability and validity of kiddie-schedule for affective disorders and schizophrenia-present and lifetime version-Korean version (K-SADS-PL-K)

Authors: Y.S. Kim, K.A. Cheon, B.N. Kim, S.A. Chang, H.J. Yoo, J.W. Kim, S.C. Cho, et al.
Journal: Yonsei Medical Journal
Volume: 45
Issue: 1
Pages: 81-89
Year: 2004

Characteristics of brains in autism spectrum disorder: structure, function and connectivity across the lifespan

Authors: S. Ha, I.J. Sohn, N. Kim, H.J. Sim, K.A. Cheon
Journal: Experimental Neurobiology
Volume: 24
Issue: 4
Pages: 273
Year: 2015

A comparison of DSM-IV pervasive developmental disorder and DSM-5 autism spectrum disorder prevalence in an epidemiologic sample

Authors: Y.S. Kim, E. Fombonne, Y.J. Koh, S.J. Kim, K.A. Cheon, B.L. Leventhal
Journal: Journal of the American Academy of Child & Adolescent Psychiatry
Volume: 53
Issue: 5
Pages: 500-508
Year: 2014